Year: 2024
Type: article
Abstract: arrhythmias; blood pressure; cardiology; hemodynamics; quality of life; rehabilitation Acute heart failure (AHF) is a significant clinical condition that often leads to hospitalization, requiring intensive treatment (1), including the use of IV inotropic drugs, to support cardiac function.Inotropic drugs improve cardiac contractility in patients with hemodynamic compromise, but prolonged immobility during treatment can result in secondary complications such as muscle atrophy, reduced functional capacity, and impaired quality of life (2).Early rehabilitation, defined as mobilization and physical therapy initiated within 2 days of admission, has emerged as a decisive strategy in improving outcomes for patients with AHF, by providing an improved hemodynamic stability and preserving muscle mass and strength.Furthermore, early rehabilitation promotes improvement in exercise tolerance and overall functional capacity, reducing fatigue and dyspnea, allowing patients to better tolerate daily activities during and after hospitalization (3).Such an improved functional capacity can also reduce hospital readmissions and enhances long-term quality of life.Prolonged immobility increases the risk of hospital-acquired complications, such as deep vein thrombosis, pressure ulcers, and respiratory infections (4).Early rehabilitation helps mitigate these risks by maintaining circulation, encouraging deep breathing, and promoting movement, thus reducing the duration of inotropic support and the risk of secondary complications.The authors have disclosed that they do not have any potential conflicts of interest.
Source: Critical Care Medicine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1000608447, G1196682224, G1214234794, G1218068299, Molecular regulation of skeletal muscle thermogenesis, G1413706045, G1512127578, G1530010185, G180476886, G186995139, Beta Cell Intracellular Calcium and Diabetes, Functional role of IP3 receptors in the regulation of cardiac myofibroblasts, G249311083, Modulation of Mitofusin Activity to Treat Heart Disease, G280444578, G281933567, G2836354684, G2940288175, A paradigm-shifting idea in storage-disease cardiomyopathy, G3074976661, G3672453180, Einstein-Montefiore Clinical and Translational Science Award Hub, Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction, Mechanisms of cardiovascular disease, G425922058, G4480573366, CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patients, G522617745, G5298350625, G531307636, G5423166509, G6295426566, G671159905, G6737277850, G7492960808, G7854002418, G790170206, G802470759, G8224181935, Purposeful Outreach for Diversity and Inclusion of Underrepresented in Medicine (PODIUM) Physician-Scientists, G8385843488, G8445767824, G864706750, G873634175, G9000020154, G9000036909, G9000045154, G9000045632, G9000148014, G9000203699, G9000291687, G981417163
OpenAlex ID: W4406296738